In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.Visa övriga samt affilieringar
2007 (Engelska)Ingår i: Hypertension, ISSN 1524-4563, Vol. 50, nr 5, s. 984-90Artikel i tidskrift (Refereegranskat) Published
Ort, förlag, år, upplaga, sidor
2007. Vol. 50, nr 5, s. 984-90
Nyckelord [en]
Aged, Aged; 80 and over, Antihypertensive Agents/therapeutic use, Atenolol/therapeutic use, Blood Pressure/drug effects, Comorbidity, Diabetes Mellitus/diagnosis/epidemiology/*prevention & control, Electrocardiography, Female, Follow-Up Studies, Humans, Hypertension/*drug therapy/epidemiology, Hypertrophy; Left Ventricular/diagnosis/*drug therapy/epidemiology, Incidence, Losartan/*therapeutic use, Male, Middle Aged, Proportional Hazards Models, Randomized Controlled Trials as Topic/statistics & numerical data, Risk Factors, Treatment Outcome
Identifikatorer
URN: urn:nbn:se:umu:diva-6928PubMedID: 17893425Scopus ID: 2-s2.0-35848953186OAI: oai:DiVA.org:umu-6928DiVA, id: diva2:146598
2007-12-282007-12-282023-03-23Bibliografiskt granskad